UBS Group’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $825K | Sell |
|
|||||
|
2025
Q2 | $358K | Sell |
|
|||||
|
2025
Q1 | $764K | Buy |
|
|||||
|
2024
Q4 | $543K | Buy |
|
|||||
|
2024
Q3 | $868K | Buy |
|
|||||
|
2024
Q2 | $1.41M | Sell |
|
|||||
|
2024
Q1 | $11.9M | Buy |
|
|||||
|
2023
Q4 | $1.74M | Buy |
|
|||||
|
2023
Q3 | $572K | Sell |
|
|||||
|
2023
Q2 | $973K | Buy |
|
|||||
|
2023
Q1 | $901K | Buy |
|
|||||
|
2022
Q4 | $905K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $0 | Sell |
|
|||||
|
2022
Q1 | $1.06M | Buy |
|
|||||
|
2021
Q4 | $1.52M | Buy |
|
|||||
|
2021
Q3 | $34K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $893K | Buy |
|